Home › Graft-Versus-Host Disease › Washington
Graft-Versus-Host Disease clinical trials in Washington, DC
5 studies for Graft-Versus-Host Disease are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
RecruitingObservational studyHealthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
RecruitingPhase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Evaluation of Patients With Immune Function Abnormalities
RecruitingObservational studyHealthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
RecruitingObservational studyHealthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant
RecruitingPhase 2
- National Institute of Health (Data Collection AND Specimen Analysis), Bethesda · 7 mi away
Graft-Versus-Host Disease trials in other cities
- Boston, MA10 studies
- New York City, NY7 studies
- Columbus, OH6 studies
- Baldwin Park, CA5 studies
- Atlanta, GA5 studies
- Pittsburgh, PA4 studies
- Tampa, FL4 studies
- Detroit, MI4 studies
- Portland, OR4 studies
- St. Louis, MO4 studies
- Miami, FL4 studies
- Seattle, WA4 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.